Cost‑effectiveness Analysis of Tislelizumab Plus Chemotherapy in Chinese Patients with Advanced or Metastatic Oesophageal Squamous Cell Carcinoma
Scientific Reports（2024）
Key words
Cost-effectiveness analysis,Tislelizumab,Oesophageal squamous cell carcinoma,RATIONALE-306,Chemotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined